IGF2BP2 and esophageal squamous cell carcinoma: The results suggest that the TMEM44-AS1-IGF2BP2-GPX4 cascade plays a role in the development and progression of ESCC, providing new diagnostic indicators and possible treatment options for individuals with ESCC [134].